Sign inGet started

Riva Alessandro

Insider CIK 1867172 · BGNE Director · BCYC Director · IPSC Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
IPSC Century Therapeutics, Inc. A Award deriv2026-06-112026-06-1274,000— $074,000SEC↗
ONC BeOne Medicines Ltd. A Award2026-06-112026-06-1518,980— $073,164SEC↗
ONC BeOne Medicines Ltd. S Sale2026-05-222026-05-27212$309.51 $65.6K0SEC↗
BCYC BICYCLE THERAPEUTICS PLC A Award deriv2026-01-022026-01-0614,761— $014,761SEC↗
BCYC BICYCLE THERAPEUTICS PLC A Award2026-01-022026-01-067,380— $019,880SEC↗
IPSC Century Therapeutics, Inc. A Award deriv2025-06-122025-06-1644,000— $044,000SEC↗
BGNE BeiGene, Ltd. A Award deriv2025-05-212025-05-2222,750— $022,750SEC↗
BGNE BeiGene, Ltd. A Award2025-05-212025-05-2210,985— $056,940SEC↗
BCYC BICYCLE THERAPEUTICS PLC A Award deriv2025-03-252025-03-2725,000— $025,000SEC↗
BCYC BICYCLE THERAPEUTICS PLC A Award2025-03-252025-03-2712,500— $012,500SEC↗
IPSC Century Therapeutics, Inc. A Award deriv2024-06-202024-06-2144,000— $044,000SEC↗
BGNE BeiGene, Ltd. A Award deriv2024-06-052024-06-0734,151— $034,151SEC↗
BGNE BeiGene, Ltd. A Award2024-06-052024-06-0716,341— $045,955SEC↗
IPSC Century Therapeutics, Inc. A Award deriv2023-06-272023-06-2944,000— $044,000SEC↗
BGNE BeiGene, Ltd. A Award deriv2023-06-152023-06-2026,975— $026,975SEC↗
BGNE BeiGene, Ltd. A Award2023-06-152023-06-2012,922— $029,614SEC↗
BGNE BeiGene, Ltd. A Award deriv2022-06-222022-06-2434,645— $034,645SEC↗
BGNE BeiGene, Ltd. A Award2022-06-222022-06-2416,692— $016,692SEC↗
IPSC Century Therapeutics, Inc. A Award deriv2022-06-092022-06-1019,872— $019,872SEC↗
BGNE BeiGene, Ltd. A Award deriv2022-02-282022-03-0222,581— $022,581SEC↗
IPSC Century Therapeutics, Inc. A Award deriv2021-06-172021-06-2119,872— $019,872SEC↗